Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Title: Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
Authors: Peirs, Sofie; Frismantas, V; Matthijssens, Filip; Van Loocke, W; Pieters, Tim; Vandamme, Niels; Lintermans, Béatrice; Dobay, MP; Berx, Geert; Poppe, Bruce; Goossens, Steven; Bornhauser, BC; Bourquin, J-P; Van Vlierberghe, Pieter
Source: LEUKEMIA ; ISSN: 0887-6924 ; ISSN: 1476-5551
Publication Year: 2017
Collection: Ghent University Academic Bibliography
Subject Terms: Medicine and Health Sciences; Biology and Life Sciences; CHRONIC LYMPHOCYTIC-LEUKEMIA; LYMPHOMA-CELLS; BROMODOMAIN INHIBITION; SELECTIVE-INHIBITION; VENETOCLAX ABT-199; ANTITUMOR-ACTIVITY; SUPER-ENHANCERS; BH3 MIMETICS; DOUBLE HIT; C-MYC
Description: Inhibition of anti-apoptotic BCL-2 (B-cell lymphoma 2) has recently emerged as a promising new therapeutic strategy for the treatment of a variety of human cancers, including leukemia. Here, we used T-cell acute lymphoblastic leukemia (T-ALL) as a model system to identify novel synergistic drug combinations with the BH3 mimetic venetoclax (ABT-199). In vitro drug screening in primary leukemia specimens that were derived from patients with high risk of relapse or relapse and cell lines revealed synergistic activity between venetoclax and the BET (bromodomain and extraterminal) bromodomain inhibitor JQ1. Notably, this drug synergism was confirmed in vivo using T-ALL cell line and patient-derived xenograft models. Moreover, the therapeutic benefit of this drug combination might, at least in part, be mediated by an acute induction of the pro-apoptotic factor BCL2L11 and concomitant reduction of BCL-2 upon BET bromodomain inhibition, ultimately resulting in an enhanced binding of BIM (encoded by BCL2L11) to BCL-2. Altogether, our work provides a rationale to develop a new type of targeted combination therapy for selected subgroups of high-risk leukemia patients.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://biblio.ugent.be/publication/8514999; https://doi.org/10.1038/leu.2017.10; https://biblio.ugent.be/publication/8514999/file/8556717; https://biblio.ugent.be/publication/8514999/file/8556718; https://biblio.ugent.be/publication/8514999/file/8556719; https://biblio.ugent.be/publication/8514999/file/8556720; https://biblio.ugent.be/publication/8514999/file/8556721; https://biblio.ugent.be/publication/8514999/file/8556722; https://biblio.ugent.be/publication/8514999/file/8556723; https://biblio.ugent.be/publication/8514999/file/8556724; https://biblio.ugent.be/publication/8514999/file/8556725; https://biblio.ugent.be/publication/8514999/file/8556726; https://biblio.ugent.be/publication/8514999/file/8556727; https://biblio.ugent.be/publication/8514999/file/8556728; https://biblio.ugent.be/publication/8514999/file/8556729; https://biblio.ugent.be/publication/8514999/file/8556730
DOI: 10.1038/leu.2017.10
Availability: https://biblio.ugent.be/publication/8514999; https://hdl.handle.net/1854/LU-8514999; https://doi.org/10.1038/leu.2017.10; https://biblio.ugent.be/publication/8514999/file/8556717; https://biblio.ugent.be/publication/8514999/file/8556718; https://biblio.ugent.be/publication/8514999/file/8556719; https://biblio.ugent.be/publication/8514999/file/8556720; https://biblio.ugent.be/publication/8514999/file/8556721; https://biblio.ugent.be/publication/8514999/file/8556722; https://biblio.ugent.be/publication/8514999/file/8556723; https://biblio.ugent.be/publication/8514999/file/8556724; https://biblio.ugent.be/publication/8514999/file/8556725; https://biblio.ugent.be/publication/8514999/file/8556726; https://biblio.ugent.be/publication/8514999/file/8556727; https://biblio.ugent.be/publication/8514999/file/8556728; https://biblio.ugent.be/publication/8514999/file/8556729; https://biblio.ugent.be/publication/8514999/file/8556730
Rights: info:eu-repo/semantics/restrictedAccess
Accession Number: edsbas.26890971
Database: BASE